Genomic classifier (ColoPrint) predicts outcome and chemotherapy benefit in stage II and III colon cancer patients

被引：0
|
作者：
Kopetz, S. [1 ]
Jiang, Z. Q. [2 ]
Overman, M. J. [1 ]
Rosenberg, R. [3 ]
Salazar, R. [4 ]
Tabernero, J. [5 ]
Stork-Sloots, L. [6 ]
Simon, I. [7 ]
Chang, G. J. [8 ]
Maru, D. M. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Kantonsspital Baden, Dept Surg, Baden, Switzerland
[4] Inst Catala Oncol IDIBELL Hospitalet de Llobregat, Dept Med Oncol, Barcelona, Spain
[5] Vail dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[6] Agendia, Med Affairs, Amsterdam, Netherlands
[7] Agendia, Res & Dev, Amsterdam, Netherlands
[8] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2257
引用
收藏
页码：S514 / S515
页数：2
相关论文
共 50 条
  • [31] The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
    Stotz, M.
    Pichler, M.
    Absenger, G.
    Szkandera, J.
    Arminger, F.
    Schaberl-Moser, R.
    Samonigg, H.
    Stojakovic, T.
    Gerger, A.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 435 - 440
  • [32] The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
    M Stotz
    M Pichler
    G Absenger
    J Szkandera
    F Arminger
    R Schaberl-Moser
    H Samonigg
    T Stojakovic
    A Gerger
    British Journal of Cancer, 2014, 110 : 435 - 440
  • [33] Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer
    Austin, Jessica D. D.
    Shelton, Elizabeth
    Crookes, Danielle M. M.
    Neugut, Alfred I. I.
    Shelton, Rachel C. C.
    MDM POLICY & PRACTICE, 2023, 8 (01)
  • [34] Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer
    Austin, J. D.
    Shelton, E.
    Crookes, D. M.
    Tehranifar, P.
    Neugut, A., I
    Shelton, R. C.
    MDM POLICY & PRACTICE, 2023, 8 (02)
  • [35] Immunomonitoring in patients with stage II and III colon cancer
    Vocka, Michal
    Spacek, Jan
    Netikova, Irena
    Zavadova, Eva
    Nemejcova, Kristyna
    Konopasek, Bohuslav
    Dundr, Pavel
    Geppert, Carol-Immanuel
    Fucikova, Terezie
    Hartmann, Arndt
    Petruzelka, Lubos B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients
    R. P. M. Brosens
    E. J. T. H. Belt
    J. C. Haan
    T. E. Buffart
    B. Carvalho
    H. Grabsch
    P. Quirke
    M. A. Cuesta
    A. F. Engel
    B. Ylstra
    G. A. Meijer
    Cellular Oncology, 2011, 34 : 215 - 223
  • [37] Deletion of chromosome 4q predicts outcome in stage II colon cancer patients
    Brosens, R. P. M.
    Belt, E. J. T. H.
    Haan, J. C.
    Buffart, T. E.
    Carvalho, B.
    Grabsch, H.
    Quirke, P.
    Cuesta, M. A.
    Engel, A. F.
    Ylstra, B.
    Meijer, G. A.
    ANALYTICAL CELLULAR PATHOLOGY, 2010, 33 (02) : 95 - 104
  • [38] Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients
    Brosens, R. P. M.
    Belt, E. J. T. H.
    Haan, J. C.
    Buffart, T. E.
    Carvalho, B.
    Grabsch, H.
    Quirke, P.
    Cuesta, M. A.
    Engel, A. F.
    Ylstra, B.
    Meijer, G. A.
    CELLULAR ONCOLOGY, 2011, 34 (03) : 215 - 223
  • [39] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [40] Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients
    Oki, Eiji
    Shinto, Eiji
    Shimokawa, Mototsugu
    Yamaguchi, Shigeki
    Ishiguro, Megumi
    Hasegawa, Seiji
    Takii, Yasumasa
    Ishida, Hideyuki
    Kusumoto, Tetsuya
    Morita, Masaru
    Tomita, Naohiro
    Shiozawa, Manabu
    Tanaka, Masafumi
    Ozawa, Heita
    Hashiguchi, Yojiro
    Ohnuma, Shinobu
    Tada, Sachiyo
    Matsushima, Tomoko
    Hase, Kazuo
    BMC CANCER, 2021, 21 (01)
12345